Cite
PSY65 Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
MLA
Väätäinen, S., et al. “PSY65 Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland.” Value in Health, no. 7, p. A670. EBSCOhost, https://doi.org/10.1016/j.jval.2015.09.2449. Accessed 25 Oct. 2024.
APA
Väätäinen, S., Soini, E., Valgardsson, V., & Mälkönen, T. (n.d.). PSY65 Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland. Value in Health, 7, A670. https://doi.org/10.1016/j.jval.2015.09.2449
Chicago
Väätäinen, S, Ej Soini, Vs Valgardsson, and T Mälkönen. 2024. “PSY65 Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland.” Value in Health, no. 7: A670. Accessed October 25. doi:10.1016/j.jval.2015.09.2449.